NCT01369576View on ClinicalTrials.gov

Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea

PHASE3CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2014

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Placebo

3.75-7.5mg 14 doses 4 weeks

DRUG

Zopiclone

3.75-7.5mg 14 doses 4 weeks

Trial Locations (4)

H7M 3L9

Cite de la Sante, Laval

H7S 2M5

Institut de medecine specialisee de Laval, Laval

H4N 1C5

Institut de Medecine du sommeil, Montreal

H4W 1S7

Mount Sinai Hospital, Montreal

Sponsors

Lead Sponsor

OSR Medical Inc.
All Listed Sponsors
lead

OSR Medical Inc.

INDUSTRY

NCT01369576 - Effect of Zopiclone on Compliance With Continuous Positive Airway Pressure in Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter